Destination Wealth Management Has $44.30 Million Position in Danaher Co. (NYSE:DHR)

Destination Wealth Management lifted its stake in Danaher Co. (NYSE:DHR - Free Report) by 1.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 159,355 shares of the conglomerate's stock after purchasing an additional 2,686 shares during the quarter. Danaher accounts for about 1.4% of Destination Wealth Management's investment portfolio, making the stock its 25th largest holding. Destination Wealth Management's holdings in Danaher were worth $44,304,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of DHR. FMR LLC increased its holdings in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the period. TD Asset Management Inc increased its stake in Danaher by 99.0% in the 2nd quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate's stock valued at $339,473,000 after buying an additional 675,952 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Danaher by 22.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock valued at $761,475,000 after buying an additional 563,546 shares during the period. International Assets Investment Management LLC grew its holdings in shares of Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after acquiring an additional 428,897 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. raised its holdings in shares of Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock worth $465,617,000 after acquiring an additional 397,671 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

DHR traded down $0.90 on Thursday, hitting $234.50. 3,988,403 shares of the stock traded hands, compared to its average volume of 2,786,486. The business has a fifty day moving average price of $248.34 and a two-hundred day moving average price of $257.78. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52 week low of $219.15 and a 52 week high of $281.70. The firm has a market capitalization of $169.37 billion, a PE ratio of 44.93, a P/E/G ratio of 4.23 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the previous year, the business posted $2.02 earnings per share. Danaher's quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date is Friday, December 27th. Danaher's payout ratio is 20.61%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on DHR shares. Barclays cut their price target on Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 23rd. TD Cowen increased their price target on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research note on Wednesday, October 23rd. Evercore ISI upped their price objective on shares of Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. Wells Fargo & Company assumed coverage on Danaher in a research report on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 price target for the company. Finally, UBS Group lowered their price objective on Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.